Newron Pharmaceuticals
NWRN.SW
#8593
Rank
A$0.22 B
Marketcap
$11.82
Share price
-5.96%
Change (1 day)
-16.97%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.79

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.79. In 2023 the company made an earnings per share (EPS) of -$1.79 a decrease over its 2022 EPS that were of -$1.76.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.792.03%
2022-$1.7615.39%
2021-$1.52-31.32%
2020-$2.2214.74%
2019-$1.9336.6%
2018-$1.41159.87%
2017-$0.54-67.81%
2016-$1.69-39.24%
2015-$2.78107.61%
2014-$1.3415.8%
2013-$1.16119.91%
2012-$0.53-66.51%
2011-$1.57-71.49%
2010-$5.51-10.83%
2009-$6.1842.06%
2008-$4.3556.53%
2007-$2.78-52.84%
2006-$5.89-188.53%
2005$6.65